BioCentury
ARTICLE | Company News

Tengion gene/cell therapy, transplant news

September 29, 2014 7:00 AM UTC

Regenerative medicine company Tengion hired Jefferies to explore strategic options. Tengion said the decision allows it to realize the value of its organ regeneration platform, but declined to comment...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article